Literature DB >> 10375132

Effect of bacteriocin-producing lactobacilli on the survival of Escherichia coli and Listeria in a dynamic model of the stomach and the small intestine.

M G Gänzle1, C Hertel, J M van der Vossen, W P Hammes.   

Abstract

The survival of Lactobacillus curvatus LTH 1174 (bac ) and (bac ) in combination with Escherichia coli LTH 1600 or Listeria innocua DSM20649 during transit through a dynamic model of the human stomach and small intestine (GIT model) was studied. Furthermore, we determined the digestion of curvacin A during gastro-intestinal transit and the effect of this bacteriocin on microbial survival. Lb. curvatus is rapidly killed in the gastric compartment at pH < 2.0, and less than 0.01% of the cells delivered to the small intestinal compartments were recovered from the ileal compartment of the model. Meat exerted a protective effect against the lethal action of bile against Lb. curvatus. The sensitivity of E. coli to acid depended on the aeration of the preculture and decreased in the order anaerobic > strongly agitated > agitated. Lactic acid and curvacin A enhanced the lethal effect of low pH on E. coli. Accordingly, cells from strongly agitated cultures were killed faster in the gastric compartment of the GIT model than those from agitated cultures, and inactivation was accelerated in the presence of curvacin A. E. coli tolerated the bile concentrations prevailing in the small intestinal compartments of the model. The survival of Listeria innocua in the GIT model was comparable to that of Lb. curvatus. The curvacin A produced by Lb. curvatus LTH1174 (bac+) killed > 90% of the L. innocua within 10 min after mixing of the cultures. Curvacin A was not degraded in the the gastric compartment, and could be detected in the ileal compartment during the first 180 min upon addition of the meal.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10375132     DOI: 10.1016/s0168-1605(99)00025-2

Source DB:  PubMed          Journal:  Int J Food Microbiol        ISSN: 0168-1605            Impact factor:   5.277


  12 in total

1.  Effect of a new probiotic Saccharomyces cerevisiae strain on survival of Escherichia coli O157:H7 in a dynamic gastrointestinal model.

Authors:  Lucie Etienne-Mesmin; Valérie Livrelli; Maud Privat; Sylvain Denis; Jean-Michel Cardot; Monique Alric; Stéphanie Blanquet-Diot
Journal:  Appl Environ Microbiol       Date:  2010-12-03       Impact factor: 4.792

2.  Compatibility, Cytotoxicity, and Gastrointestinal Tenacity of Bacteriocin-Producing Bacteria Selected for a Consortium Probiotic Formulation to Be Used in Livestock Feed.

Authors:  Mégane Eveno; Patricia Savard; Yanath Belguesmia; Laurent Bazinet; Frédérique Gancel; Djamel Drider; Ismail Fliss
Journal:  Probiotics Antimicrob Proteins       Date:  2021-02       Impact factor: 4.609

3.  Bile acids improve the antimicrobial effect of rifaximin.

Authors:  Charles Darkoh; Lenard M Lichtenberger; Nadim Ajami; Elizabeth J Dial; Zhi-Dong Jiang; Herbert L DuPont
Journal:  Antimicrob Agents Chemother       Date:  2010-06-14       Impact factor: 5.191

4.  Role of mucus-bacteria interactions in Enterotoxigenic Escherichia coli (ETEC) H10407 virulence and interplay with human microbiome.

Authors:  Lucie Etienne-Mesmin; Stéphanie Blanquet-Diot; Thomas Sauvaitre; Josefien Van Landuyt; Claude Durif; Charlène Roussel; Adeline Sivignon; Sandrine Chalancon; Ophélie Uriot; Florence Van Herreweghen; Tom Van de Wiele
Journal:  NPJ Biofilms Microbiomes       Date:  2022-10-20       Impact factor: 8.462

5.  Injection of Lactobacillus casei strain Shirota affects autonomic nerve activities in a tissue-specific manner, and regulates glucose and lipid metabolism in rats.

Authors:  Mamoru Tanida; Kazuki Imanishi; Haruna Akashi; Yasutaka Kurata; Osamu Chonan; Eiichiro Naito; Satoru Kunihiro; Mitsuhisa Kawai; Akito Kato-Kataoka; Toshishige Shibamoto
Journal:  J Diabetes Investig       Date:  2013-11-05       Impact factor: 4.232

6.  Survival of pathogenic and lactobacilli species of fermented olives during simulated human digestion.

Authors:  Francisco N Arroyo-López; Stéphanie Blanquet-Diot; Sylvain Denis; Jonathan Thévenot; Sandrine Chalancon; Monique Alric; Francisco Rodríguez-Gómez; Verónica Romero-Gil; Rufino Jiménez-Díaz; Antonio Garrido-Fernández
Journal:  Front Microbiol       Date:  2014-10-14       Impact factor: 5.640

Review 7.  Impact of Microbes on the Pathogenesis of Primary Biliary Cirrhosis (PBC) and Primary Sclerosing Cholangitis (PSC).

Authors:  Jochen Mattner
Journal:  Int J Mol Sci       Date:  2016-11-09       Impact factor: 5.923

8.  Inactivation of Bacillus cereus vegetative cells by gastric acid and bile during in vitro gastrointestinal transit.

Authors:  Siele Ceuppens; Mieke Uyttendaele; Stefanie Hamelink; Nico Boon; Tom Van de Wiele
Journal:  Gut Pathog       Date:  2012-10-03       Impact factor: 4.181

9.  Use of Potential Probiotic Lactic Acid Bacteria (LAB) Biofilms for the Control of Listeria monocytogenes, Salmonella Typhimurium, and Escherichia coli O157:H7 Biofilms Formation.

Authors:  Natacha C Gómez; Juan M P Ramiro; Beatriz X V Quecan; Bernadette D G de Melo Franco
Journal:  Front Microbiol       Date:  2016-06-10       Impact factor: 5.640

10.  Technological properties and probiotic potential of Lactobacillus fermentum strains isolated from West African fermented millet dough.

Authors:  James Owusu-Kwarteng; Kwaku Tano-Debrah; Fortune Akabanda; Lene Jespersen
Journal:  BMC Microbiol       Date:  2015-11-11       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.